ArticleFrontiers in oncology2021

Volume of Disease as a Predictor for Clinical Outcomes in Patients With Melanoma Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Therapy.

Aidan M Burke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.